• Petitioned Robert J. Coury, CEO & Chairman of the Board

This petition was delivered to:

Mylan
Robert J. Coury, CEO & Chairman of the Board
Hospira Pharmaceutical Company
Michael Ball, Chief Executive
Bedford Laboratories
David Gaugh, Vice President
APP Pharmaceuticals
John Ducker, CEO

Continue making the injection drug methotrexate for children with leukemia

    1. Rebekah Arrington
    2. Petition by

      Rebekah Arrington

      Niceville, FL

Medication used to treat the most common form of childhood leukemia is in short supply, adding to the largest nationwide shortage of critical lifesaving hospital medications in nearly a decade.

All five pharmaceutical companies that make the injection drug methotrexate, which treats acute lymphoblastic leukemia by slowing the growth of cancer cells, have either slowed and stopped manufacturing of the drug, according to the U.S. Food and Drug Administration. The companies have cited high demand or manufacturing delays as reasons for the shortage.

If the shortage continues, physicians and pharmacists fear thousands of children will be left without lifesaving treatment.

"This, to us in oncology, is a national crisis," said Brooke Bernhardt, clinical pharmacy specialist in the department of hematology and oncology at Texas Children's Hospital in Houston.

According to Dr. Michael Link, pediatric oncologist and president of the American Society of Clinical Oncology, some hospital pharmacies have reported having only a couple weeks of supply left.

Many oncologists are especially worried about the shortage of the preservative-free form of methotrexate, which is considered less toxic.

Only the preservative-free methotrexate can be injected into the spinal fluid of cancer patients to prevent the spread and recurrence of the disease.

"There are couple other drugs that can be injected into the spinal fluid, but none that are as effective," said Link. "As for the high dose version of the drug, there's no workaround for it."
Each year, nearly 3,000 children and adolescents under age 20 are diagnosed with acute lymphoblastic leukemia in the United States, according to the National Cancer Institute. Eighty percent of children are successfully treated.

The agency said it's uncertain when the next batch of methotrexate will be available.

Let these drug companies know who they are hurting...CHILDREN!
APP Pharmaceutical Company
John Ducker , CEO & President
1501 East Woodfield Rd
Schaumburg, IL 60173

Bedford Laboratories
David Gaugh, Vice President & General Manager
300 Northfield Rd
Bedford, OH 44146

Hospira Pharmaceutical Company
Michael Ball, Chief Executive
275 North Field Dr
Lake Forest, IL 60045

Mylan
Robert J. Coury, CEO & Chairman of the Board
1500 Corporate Dr
Canonsburg, PA 15317

Recent signatures

    News

    1. Reached 1,000 signatures

    Supporters

    Reasons for signing

    • trent taylor AMERICA, TX
      • over 2 years ago

      because anything that helps our children to be cured or delay the inevitable or manage or tolerate such ailments should not under any circumstance be taken from them

      REPORT THIS COMMENT:
    • Chant Macleod WALDWICK, NJ
      • over 2 years ago

      The lives of human beings should NEVER take a back seat to a profit margin.

      REPORT THIS COMMENT:
    • Lori Chek FUQUAY VARINA, NC
      • over 2 years ago

      In honor of Devon Murphy and Hailey Howard. They need this medicine!!!!!

      REPORT THIS COMMENT:
    • Chris Frey ST. CHARLES, MO
      • over 2 years ago

      I am a cancer survivor and volunteer and have heard from my clinic about the potentially critical shortage of cancer drugs that are necessary for treatment, but less profitable for manufacturers. I hope this problem will be be corrected immediately.

      REPORT THIS COMMENT:
    • ellen hoffman CHARLESTON, SC
      • over 2 years ago

      methotrexate is important for children with leukemia. it saves their lives!

      REPORT THIS COMMENT:

    Develop your own tools to win.

    Use the Change.org API to develop your own organizing tools. Find out how to get started.